321 related articles for article (PubMed ID: 15359575)
1. Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation.
Porter CJ; Kaukonen AM; Boyd BJ; Edwards GA; Charman WN
Pharm Res; 2004 Aug; 21(8):1405-12. PubMed ID: 15359575
[TBL] [Abstract][Full Text] [Related]
2. Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs.
Cuiné JF; Charman WN; Pouton CW; Edwards GA; Porter CJ
Pharm Res; 2007 Apr; 24(4):748-57. PubMed ID: 17372700
[TBL] [Abstract][Full Text] [Related]
3. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
Anby MU; Nguyen TH; Yeap YY; Feeney OM; Williams HD; Benameur H; Pouton CW; Porter CJ
Mol Pharm; 2014 Nov; 11(11):4069-83. PubMed ID: 25265395
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs.
Cuiné JF; McEvoy CL; Charman WN; Pouton CW; Edwards GA; Benameur H; Porter CJ
J Pharm Sci; 2008 Feb; 97(2):995-1012. PubMed ID: 18064698
[TBL] [Abstract][Full Text] [Related]
5. Incomplete desorption of liquid excipients reduces the in vitro and in vivo performance of self-emulsifying drug delivery systems solidified by adsorption onto an inorganic mesoporous carrier.
Van Speybroeck M; Williams HD; Nguyen TH; Anby MU; Porter CJ; Augustijns P
Mol Pharm; 2012 Sep; 9(9):2750-60. PubMed ID: 22870936
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
Grove M; Müllertz A; Nielsen JL; Pedersen GP
Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738
[TBL] [Abstract][Full Text] [Related]
7. Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
McEvoy CL; Trevaskis NL; Feeney OM; Edwards GA; Perlman ME; Ambler CM; Porter CJH
Mol Pharm; 2017 Dec; 14(12):4525-4538. PubMed ID: 29076741
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
Fei Y; Kostewicz ES; Sheu MT; Dressman JB
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
[TBL] [Abstract][Full Text] [Related]
9. Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.
Vithani K; Hawley A; Jannin V; Pouton C; Boyd BJ
Eur J Pharm Biopharm; 2018 Sep; 130():236-246. PubMed ID: 29981444
[TBL] [Abstract][Full Text] [Related]
10. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation.
Han SF; Yao TT; Zhang XX; Gan L; Zhu C; Yu HZ; Gan Y
Int J Pharm; 2009 Sep; 379(1):18-24. PubMed ID: 19508887
[TBL] [Abstract][Full Text] [Related]
11. 'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.
Feeney OM; Williams HD; Pouton CW; Porter CJ
J Control Release; 2014 Oct; 192():219-27. PubMed ID: 25058571
[TBL] [Abstract][Full Text] [Related]
12. The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations.
Weng T; Qi J; Lu Y; Wang K; Tian Z; Hu K; Yin Z; Wu W
J Nanobiotechnology; 2014 Sep; 12():39. PubMed ID: 25248304
[TBL] [Abstract][Full Text] [Related]
13. Examination of the impact of a range of Pluronic surfactants on the in-vitro solubilisation behaviour and oral bioavailability of lipidic formulations of atovaquone.
Sek L; Boyd BJ; Charman WN; Porter CJ
J Pharm Pharmacol; 2006 Jun; 58(6):809-20. PubMed ID: 16734982
[TBL] [Abstract][Full Text] [Related]
14. The in vitro and in vivo evaluation of fenofibrate with a self- microemulsifying formulation.
Xiumin LI; Man GE; Minzi LU; Yinghua J; Dongqin Q
Curr Drug Deliv; 2015; 12(3):308-13. PubMed ID: 26054534
[TBL] [Abstract][Full Text] [Related]
15. Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.
Mohsin K
AAPS PharmSciTech; 2012 Jun; 13(2):637-46. PubMed ID: 22547370
[TBL] [Abstract][Full Text] [Related]
16. Impact of solidification on the performance of lipid-based colloidal carriers: oil-based versus self-emulsifying systems.
Alinaghi A; Tan A; Rao S; Prestidge CA
Curr Drug Deliv; 2015; 12(1):16-25. PubMed ID: 25030115
[TBL] [Abstract][Full Text] [Related]
17. Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead.
Dokania S; Joshi AK
Drug Deliv; 2015; 22(6):675-90. PubMed ID: 24670091
[TBL] [Abstract][Full Text] [Related]
18. Danazol oral absorption modelling in the fasted dog: An example of mechanistic understanding of formulation effects on drug pharmacokinetics.
Pade D; Jamei M; Turner DB; Mistry B; Martinez MN
Eur J Pharm Biopharm; 2019 Aug; 141():191-209. PubMed ID: 31150808
[TBL] [Abstract][Full Text] [Related]
19. Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs.
Vithani K; Jannin V; Pouton CW; Boyd BJ
Adv Drug Deliv Rev; 2019 Mar; 142():16-34. PubMed ID: 30677448
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.
Cui J; Yu B; Zhao Y; Zhu W; Li H; Lou H; Zhai G
Int J Pharm; 2009 Apr; 371(1-2):148-55. PubMed ID: 19124065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
